Matthew Daley
Concepts (432)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccination | 88 | 2024 | 1205 | 8.140 |
Why?
| Vaccines | 35 | 2024 | 376 | 6.660 |
Why?
| Influenza Vaccines | 40 | 2023 | 497 | 5.030 |
Why?
| Immunization Schedule | 28 | 2024 | 184 | 3.930 |
Why?
| Vaccination Coverage | 12 | 2023 | 63 | 3.760 |
Why?
| Influenza, Human | 29 | 2023 | 546 | 3.580 |
Why?
| Papillomavirus Vaccines | 15 | 2022 | 223 | 2.970 |
Why?
| Immunization Programs | 17 | 2022 | 206 | 2.870 |
Why?
| Papillomavirus Infections | 10 | 2022 | 262 | 2.600 |
Why?
| Immunization | 22 | 2024 | 402 | 2.380 |
Why?
| Adverse Drug Reaction Reporting Systems | 14 | 2022 | 68 | 2.250 |
Why?
| Health Knowledge, Attitudes, Practice | 16 | 2021 | 1183 | 2.130 |
Why?
| Advisory Committees | 17 | 2024 | 208 | 2.030 |
Why?
| Electronic Health Records | 24 | 2023 | 802 | 2.010 |
Why?
| Child, Preschool | 75 | 2023 | 9086 | 1.970 |
Why?
| Patient Acceptance of Health Care | 13 | 2022 | 679 | 1.760 |
Why?
| School Health Services | 11 | 2018 | 206 | 1.710 |
Why?
| Parents | 16 | 2023 | 1191 | 1.700 |
Why?
| Eczema | 3 | 2022 | 82 | 1.700 |
Why?
| Infant | 70 | 2024 | 7937 | 1.690 |
Why?
| Social Media | 4 | 2021 | 133 | 1.660 |
Why?
| Child | 97 | 2024 | 18366 | 1.620 |
Why?
| United States | 79 | 2024 | 12211 | 1.510 |
Why?
| Humans | 205 | 2024 | 114937 | 1.400 |
Why?
| Adolescent | 81 | 2024 | 17829 | 1.340 |
Why?
| Pregnancy Complications, Infectious | 4 | 2022 | 287 | 1.330 |
Why?
| Reminder Systems | 6 | 2016 | 162 | 1.310 |
Why?
| Female | 131 | 2023 | 59581 | 1.260 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 10 | 2022 | 243 | 1.260 |
Why?
| Practice Patterns, Physicians' | 16 | 2014 | 1177 | 1.250 |
Why?
| Information Dissemination | 2 | 2020 | 188 | 1.120 |
Why?
| Male | 114 | 2023 | 55663 | 1.110 |
Why?
| Pediatric Obesity | 7 | 2022 | 489 | 1.070 |
Why?
| Pediatrics | 17 | 2020 | 984 | 1.060 |
Why?
| Measles | 3 | 2022 | 38 | 1.010 |
Why?
| Colorado | 30 | 2022 | 4091 | 1.000 |
Why?
| Product Surveillance, Postmarketing | 6 | 2017 | 63 | 0.980 |
Why?
| Hypertension | 7 | 2018 | 1059 | 0.950 |
Why?
| Body Mass Index | 13 | 2022 | 1961 | 0.930 |
Why?
| Practice Guidelines as Topic | 13 | 2021 | 1400 | 0.920 |
Why?
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 9 | 2023 | 89 | 0.910 |
Why?
| Thrombocytopenia | 3 | 2022 | 177 | 0.880 |
Why?
| Asthma | 5 | 2022 | 2042 | 0.870 |
Why?
| Data Collection | 16 | 2017 | 623 | 0.870 |
Why?
| Attitude of Health Personnel | 13 | 2020 | 978 | 0.850 |
Why?
| Egg Hypersensitivity | 1 | 2022 | 45 | 0.800 |
Why?
| Pneumococcal Vaccines | 6 | 2022 | 132 | 0.800 |
Why?
| Retrospective Studies | 35 | 2023 | 12544 | 0.780 |
Why?
| Adult | 64 | 2024 | 30608 | 0.770 |
Why?
| Obesity | 7 | 2022 | 2514 | 0.770 |
Why?
| Ambulatory Care | 4 | 2020 | 479 | 0.760 |
Why?
| Data Mining | 3 | 2022 | 100 | 0.750 |
Why?
| Blood Pressure | 4 | 2018 | 1537 | 0.740 |
Why?
| Rotavirus Vaccines | 6 | 2022 | 48 | 0.740 |
Why?
| Whooping Cough | 6 | 2023 | 49 | 0.730 |
Why?
| Anti-Bacterial Agents | 5 | 2022 | 1477 | 0.730 |
Why?
| Disabled Persons | 1 | 2022 | 130 | 0.720 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 3 | 2018 | 25 | 0.720 |
Why?
| Vaccination Refusal | 2 | 2018 | 69 | 0.710 |
Why?
| Anti-Infective Agents, Urinary | 1 | 2020 | 13 | 0.700 |
Why?
| Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 364 | 0.700 |
Why?
| Reimbursement Mechanisms | 3 | 2018 | 77 | 0.690 |
Why?
| Education, Medical, Continuing | 1 | 2021 | 119 | 0.690 |
Why?
| Geographic Information Systems | 1 | 2020 | 37 | 0.690 |
Why?
| Guideline Adherence | 7 | 2015 | 490 | 0.680 |
Why?
| Syncope | 2 | 2017 | 37 | 0.680 |
Why?
| Young Adult | 41 | 2023 | 10478 | 0.670 |
Why?
| Internet | 5 | 2018 | 599 | 0.660 |
Why?
| Anaphylaxis | 3 | 2019 | 148 | 0.660 |
Why?
| Information Storage and Retrieval | 2 | 2020 | 108 | 0.650 |
Why?
| Family Practice | 8 | 2015 | 427 | 0.650 |
Why?
| Peanut Hypersensitivity | 1 | 2022 | 199 | 0.650 |
Why?
| Population Surveillance | 7 | 2020 | 392 | 0.630 |
Why?
| Vaccines, Attenuated | 7 | 2023 | 112 | 0.620 |
Why?
| Urinary Tract Infections | 1 | 2020 | 133 | 0.620 |
Why?
| Incidence | 17 | 2021 | 2316 | 0.610 |
Why?
| Healthcare Disparities | 1 | 2023 | 480 | 0.610 |
Why?
| Delivery of Health Care | 5 | 2019 | 834 | 0.610 |
Why?
| Rural Population | 3 | 2020 | 447 | 0.600 |
Why?
| Cohort Studies | 27 | 2023 | 4903 | 0.600 |
Why?
| Montana | 3 | 2023 | 16 | 0.600 |
Why?
| Drug Hypersensitivity | 2 | 2019 | 85 | 0.580 |
Why?
| Learning | 1 | 2021 | 352 | 0.570 |
Why?
| Poliovirus Vaccine, Inactivated | 2 | 2014 | 22 | 0.570 |
Why?
| Pregnant Women | 3 | 2023 | 131 | 0.560 |
Why?
| Abortion, Spontaneous | 3 | 2023 | 90 | 0.560 |
Why?
| Hepatitis B Vaccines | 3 | 2018 | 46 | 0.560 |
Why?
| Surveys and Questionnaires | 13 | 2022 | 4635 | 0.550 |
Why?
| Disease Outbreaks | 3 | 2011 | 309 | 0.540 |
Why?
| Prehypertension | 2 | 2013 | 24 | 0.540 |
Why?
| Databases, Pharmaceutical | 1 | 2016 | 5 | 0.530 |
Why?
| Aluminum | 3 | 2022 | 34 | 0.530 |
Why?
| Treatment Refusal | 3 | 2013 | 85 | 0.520 |
Why?
| Mothers | 2 | 2019 | 651 | 0.520 |
Why?
| Professional-Family Relations | 2 | 2015 | 132 | 0.520 |
Why?
| Computers, Handheld | 1 | 2016 | 24 | 0.520 |
Why?
| Urban Population | 2 | 2020 | 402 | 0.500 |
Why?
| Risk Assessment | 15 | 2022 | 2975 | 0.500 |
Why?
| Overweight | 5 | 2020 | 472 | 0.490 |
Why?
| Seasons | 9 | 2023 | 449 | 0.490 |
Why?
| Quality Assurance, Health Care | 3 | 2014 | 313 | 0.490 |
Why?
| Pregnancy | 14 | 2023 | 5527 | 0.490 |
Why?
| Consumer Health Information | 1 | 2015 | 47 | 0.490 |
Why?
| Bias | 7 | 2021 | 180 | 0.480 |
Why?
| Safety | 5 | 2018 | 297 | 0.470 |
Why?
| Age Factors | 11 | 2022 | 2891 | 0.470 |
Why?
| Deductibles and Coinsurance | 1 | 2014 | 9 | 0.460 |
Why?
| Middle Aged | 42 | 2023 | 26806 | 0.460 |
Why?
| Decision Making | 3 | 2018 | 781 | 0.450 |
Why?
| Databases, Factual | 7 | 2019 | 1125 | 0.450 |
Why?
| Primary Health Care | 10 | 2023 | 1515 | 0.430 |
Why?
| Dental Hygienists | 1 | 2013 | 12 | 0.430 |
Why?
| Pneumococcal Infections | 2 | 2022 | 91 | 0.430 |
Why?
| Chronic Disease | 5 | 2022 | 1593 | 0.420 |
Why?
| Drug Approval | 6 | 2021 | 78 | 0.410 |
Why?
| Central Nervous System Stimulants | 1 | 2014 | 139 | 0.410 |
Why?
| Health Care Surveys | 8 | 2013 | 539 | 0.410 |
Why?
| Trust | 1 | 2013 | 105 | 0.410 |
Why?
| Patient Compliance | 1 | 2016 | 526 | 0.400 |
Why?
| Measles-Mumps-Rubella Vaccine | 5 | 2022 | 40 | 0.390 |
Why?
| Vaccines, Inactivated | 6 | 2020 | 68 | 0.380 |
Why?
| Infant, Newborn | 12 | 2023 | 5035 | 0.380 |
Why?
| Attitude to Health | 4 | 2018 | 406 | 0.380 |
Why?
| Haemophilus Vaccines | 3 | 2020 | 27 | 0.370 |
Why?
| Community Health Services | 1 | 2013 | 212 | 0.370 |
Why?
| Myocarditis | 2 | 2022 | 93 | 0.370 |
Why?
| Licensure, Medical | 1 | 2010 | 12 | 0.360 |
Why?
| Risk Factors | 14 | 2020 | 8637 | 0.360 |
Why?
| Hepatitis B | 2 | 2018 | 51 | 0.350 |
Why?
| Insurance, Health | 4 | 2018 | 244 | 0.350 |
Why?
| Mass Screening | 2 | 2014 | 1011 | 0.340 |
Why?
| Multivariate Analysis | 5 | 2013 | 1440 | 0.340 |
Why?
| Herpes Zoster Vaccine | 4 | 2023 | 159 | 0.340 |
Why?
| Pandemics | 6 | 2023 | 1325 | 0.340 |
Why?
| Patient-Centered Care | 2 | 2013 | 473 | 0.340 |
Why?
| Prevalence | 9 | 2022 | 2252 | 0.330 |
Why?
| Heart Defects, Congenital | 3 | 2020 | 665 | 0.330 |
Why?
| Phentermine | 2 | 2019 | 8 | 0.330 |
Why?
| Premature Birth | 2 | 2023 | 276 | 0.320 |
Why?
| Anti-Obesity Agents | 2 | 2019 | 45 | 0.320 |
Why?
| Proportional Hazards Models | 7 | 2021 | 1080 | 0.320 |
Why?
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 3 | 2018 | 15 | 0.310 |
Why?
| Natural Language Processing | 2 | 2019 | 71 | 0.310 |
Why?
| Insurance, Health, Reimbursement | 3 | 2014 | 88 | 0.300 |
Why?
| Risk | 6 | 2022 | 815 | 0.290 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 928 | 0.290 |
Why?
| Logistic Models | 7 | 2019 | 1844 | 0.290 |
Why?
| Rotavirus Infections | 3 | 2021 | 50 | 0.280 |
Why?
| Vaccines, Synthetic | 3 | 2021 | 125 | 0.280 |
Why?
| Vaccines, Combined | 4 | 2023 | 46 | 0.280 |
Why?
| Autism Spectrum Disorder | 2 | 2022 | 323 | 0.250 |
Why?
| Meningococcal Vaccines | 4 | 2022 | 48 | 0.250 |
Why?
| Cluster Analysis | 2 | 2023 | 460 | 0.240 |
Why?
| Travel | 2 | 2023 | 121 | 0.240 |
Why?
| Poisson Distribution | 5 | 2018 | 72 | 0.240 |
Why?
| Seizures | 3 | 2018 | 340 | 0.240 |
Why?
| Guillain-Barre Syndrome | 3 | 2014 | 21 | 0.240 |
Why?
| Neoplasms | 1 | 2018 | 2106 | 0.230 |
Why?
| Health Policy | 2 | 2023 | 334 | 0.230 |
Why?
| Physicians, Family | 3 | 2011 | 201 | 0.230 |
Why?
| International Classification of Diseases | 2 | 2020 | 117 | 0.230 |
Why?
| Gastrointestinal Diseases | 3 | 2018 | 183 | 0.220 |
Why?
| Models, Theoretical | 2 | 2020 | 516 | 0.220 |
Why?
| Epidural Neoplasms | 1 | 2003 | 1 | 0.220 |
Why?
| Time Factors | 13 | 2022 | 6125 | 0.220 |
Why?
| Tetanus | 1 | 2023 | 25 | 0.220 |
Why?
| Regression Analysis | 3 | 2014 | 947 | 0.220 |
Why?
| Herpes Zoster | 2 | 2023 | 333 | 0.220 |
Why?
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2022 | 4 | 0.210 |
Why?
| Prospective Studies | 8 | 2023 | 6218 | 0.210 |
Why?
| Internal Medicine | 3 | 2010 | 211 | 0.210 |
Why?
| Library Surveys | 1 | 2022 | 1 | 0.210 |
Why?
| Cholera Vaccines | 1 | 2022 | 1 | 0.210 |
Why?
| Chorioamnionitis | 1 | 2023 | 36 | 0.210 |
Why?
| Typhoid-Paratyphoid Vaccines | 1 | 2022 | 4 | 0.210 |
Why?
| Burkitt Lymphoma | 1 | 2003 | 52 | 0.210 |
Why?
| Cholera | 1 | 2022 | 7 | 0.210 |
Why?
| Chickenpox Vaccine | 4 | 2022 | 69 | 0.200 |
Why?
| Sentinel Surveillance | 2 | 2016 | 38 | 0.200 |
Why?
| Health Planning Guidelines | 1 | 2022 | 25 | 0.200 |
Why?
| Seizures, Febrile | 1 | 2022 | 19 | 0.200 |
Why?
| Urticaria | 1 | 2022 | 50 | 0.200 |
Why?
| Influenza A Virus, H1N1 Subtype | 3 | 2013 | 139 | 0.200 |
Why?
| Aged | 15 | 2023 | 19122 | 0.200 |
Why?
| Exanthema | 1 | 2022 | 76 | 0.200 |
Why?
| Mucocutaneous Lymph Node Syndrome | 1 | 2022 | 76 | 0.200 |
Why?
| Minnesota | 3 | 2017 | 134 | 0.200 |
Why?
| Hepatitis A Vaccines | 2 | 2019 | 15 | 0.190 |
Why?
| Rotavirus | 1 | 2021 | 22 | 0.190 |
Why?
| Pharmacoepidemiology | 1 | 2021 | 20 | 0.190 |
Why?
| Infant, Small for Gestational Age | 1 | 2022 | 76 | 0.190 |
Why?
| Uterine Cervical Neoplasms | 2 | 2014 | 217 | 0.180 |
Why?
| Body Height | 1 | 2022 | 180 | 0.180 |
Why?
| Arachis | 1 | 2022 | 147 | 0.180 |
Why?
| Models, Statistical | 4 | 2023 | 604 | 0.180 |
Why?
| Papillomaviridae | 2 | 2018 | 102 | 0.180 |
Why?
| Weight Loss | 3 | 2019 | 642 | 0.180 |
Why?
| Case-Control Studies | 10 | 2021 | 3008 | 0.180 |
Why?
| Bursitis | 1 | 2020 | 8 | 0.180 |
Why?
| Managed Care Programs | 4 | 2015 | 133 | 0.180 |
Why?
| Pyelonephritis | 1 | 2020 | 7 | 0.180 |
Why?
| Antigens | 2 | 2021 | 318 | 0.180 |
Why?
| Immunologic Factors | 1 | 2022 | 221 | 0.180 |
Why?
| Cephalexin | 1 | 2020 | 8 | 0.170 |
Why?
| Cystitis | 1 | 2020 | 20 | 0.170 |
Why?
| Hospitalization | 5 | 2023 | 1754 | 0.170 |
Why?
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 39 | 0.170 |
Why?
| Public Health | 2 | 2022 | 434 | 0.170 |
Why?
| Interrupted Time Series Analysis | 1 | 2020 | 44 | 0.170 |
Why?
| Hepatitis A Virus, Human | 1 | 2019 | 2 | 0.170 |
Why?
| Socioeconomic Factors | 2 | 2020 | 1081 | 0.170 |
Why?
| Hepatitis A | 1 | 2019 | 26 | 0.170 |
Why?
| Medical Record Linkage | 1 | 2020 | 53 | 0.170 |
Why?
| California | 2 | 2019 | 363 | 0.170 |
Why?
| Epidemiological Monitoring | 1 | 2019 | 47 | 0.170 |
Why?
| Vaccine Potency | 1 | 2019 | 6 | 0.170 |
Why?
| Appetite Depressants | 1 | 2019 | 18 | 0.170 |
Why?
| Libraries, Medical | 1 | 2019 | 9 | 0.160 |
Why?
| Intention | 1 | 2020 | 143 | 0.160 |
Why?
| Dermatitis, Atopic | 1 | 2022 | 307 | 0.160 |
Why?
| Longitudinal Studies | 2 | 2022 | 2382 | 0.160 |
Why?
| Delivery of Health Care, Integrated | 3 | 2021 | 229 | 0.160 |
Why?
| Sunburn | 1 | 2018 | 25 | 0.160 |
Why?
| Patient Participation | 2 | 2012 | 360 | 0.160 |
Why?
| Physicians | 4 | 2012 | 772 | 0.160 |
Why?
| Nevus | 1 | 2018 | 26 | 0.160 |
Why?
| Environment | 1 | 2020 | 334 | 0.160 |
Why?
| Primary Ovarian Insufficiency | 1 | 2018 | 30 | 0.150 |
Why?
| Self Report | 1 | 2022 | 696 | 0.150 |
Why?
| Shoulder Joint | 1 | 2020 | 159 | 0.150 |
Why?
| Condylomata Acuminata | 1 | 2018 | 6 | 0.150 |
Why?
| Sex Factors | 3 | 2021 | 1721 | 0.150 |
Why?
| Communicable Diseases | 1 | 2020 | 130 | 0.150 |
Why?
| New Zealand | 1 | 2018 | 41 | 0.150 |
Why?
| Infant, Premature | 1 | 2022 | 478 | 0.150 |
Why?
| Biometry | 1 | 2018 | 63 | 0.150 |
Why?
| Thrombosis | 1 | 2021 | 297 | 0.150 |
Why?
| Odds Ratio | 6 | 2019 | 954 | 0.150 |
Why?
| Rhinitis, Allergic | 1 | 2018 | 35 | 0.150 |
Why?
| Blood Pressure Determination | 2 | 2015 | 122 | 0.150 |
Why?
| Parental Consent | 2 | 2014 | 22 | 0.140 |
Why?
| United Kingdom | 1 | 2018 | 227 | 0.140 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 61 | 0.140 |
Why?
| Cost-Benefit Analysis | 3 | 2015 | 546 | 0.140 |
Why?
| Firearms | 1 | 2022 | 294 | 0.140 |
Why?
| Australia | 1 | 2018 | 207 | 0.140 |
Why?
| Health Status Disparities | 1 | 2019 | 201 | 0.140 |
Why?
| Body Weight | 2 | 2018 | 868 | 0.140 |
Why?
| Siblings | 1 | 2018 | 223 | 0.140 |
Why?
| Inflammatory Bowel Diseases | 1 | 2021 | 287 | 0.140 |
Why?
| Family Health | 1 | 2018 | 194 | 0.140 |
Why?
| Health Maintenance Organizations | 2 | 2014 | 93 | 0.140 |
Why?
| Maternal Exposure | 1 | 2018 | 138 | 0.140 |
Why?
| Vaccines, Conjugate | 3 | 2022 | 60 | 0.140 |
Why?
| Diagnostic Errors | 1 | 2018 | 151 | 0.140 |
Why?
| Cardiovascular Diseases | 2 | 2019 | 1729 | 0.140 |
Why?
| Cross-Sectional Studies | 8 | 2022 | 4407 | 0.140 |
Why?
| Diastole | 1 | 2017 | 131 | 0.140 |
Why?
| Systole | 1 | 2017 | 171 | 0.140 |
Why?
| United States Food and Drug Administration | 3 | 2021 | 172 | 0.140 |
Why?
| Reproducibility of Results | 3 | 2019 | 2770 | 0.130 |
Why?
| Infectious Disease Transmission, Vertical | 1 | 2017 | 152 | 0.130 |
Why?
| Health Services Research | 3 | 2022 | 371 | 0.130 |
Why?
| Pilot Projects | 2 | 2022 | 1372 | 0.130 |
Why?
| Registries | 4 | 2011 | 1760 | 0.130 |
Why?
| Ultraviolet Rays | 1 | 2018 | 366 | 0.130 |
Why?
| Data Accuracy | 1 | 2016 | 48 | 0.130 |
Why?
| Public Health Surveillance | 3 | 2020 | 61 | 0.130 |
Why?
| Needs Assessment | 1 | 2017 | 315 | 0.120 |
Why?
| Pneumonia, Viral | 1 | 2020 | 342 | 0.120 |
Why?
| Focus Groups | 2 | 2014 | 385 | 0.120 |
Why?
| Coronavirus Infections | 1 | 2020 | 334 | 0.120 |
Why?
| Diabetes Mellitus, Type 1 | 2 | 2021 | 3248 | 0.120 |
Why?
| Breast Feeding | 1 | 2018 | 370 | 0.120 |
Why?
| Contraceptives, Oral | 1 | 2014 | 25 | 0.120 |
Why?
| Social Welfare | 1 | 2014 | 20 | 0.120 |
Why?
| Adjuvants, Immunologic | 1 | 2015 | 206 | 0.120 |
Why?
| Program Evaluation | 1 | 2018 | 824 | 0.120 |
Why?
| Direct Service Costs | 1 | 2014 | 10 | 0.120 |
Why?
| Food Hypersensitivity | 1 | 2018 | 254 | 0.110 |
Why?
| Respiratory Tract Infections | 2 | 2018 | 321 | 0.110 |
Why?
| Research Design | 4 | 2022 | 932 | 0.110 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2019 | 452 | 0.110 |
Why?
| Costs and Cost Analysis | 1 | 2014 | 195 | 0.110 |
Why?
| Aged, 80 and over | 7 | 2020 | 6364 | 0.110 |
Why?
| Health Promotion | 1 | 2019 | 686 | 0.100 |
Why?
| Dyslipidemias | 1 | 2014 | 154 | 0.100 |
Why?
| Follow-Up Studies | 5 | 2020 | 4427 | 0.100 |
Why?
| Computer Simulation | 2 | 2013 | 880 | 0.100 |
Why?
| Venous Thromboembolism | 1 | 2015 | 231 | 0.100 |
Why?
| Maternal Age | 2 | 2023 | 117 | 0.100 |
Why?
| Health Services | 1 | 2013 | 103 | 0.100 |
Why?
| Environmental Exposure | 1 | 2015 | 377 | 0.100 |
Why?
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 12 | 0.100 |
Why?
| RNA, Messenger | 3 | 2023 | 2559 | 0.100 |
Why?
| Diabetes Mellitus | 1 | 2019 | 904 | 0.100 |
Why?
| Skin Neoplasms | 1 | 2018 | 762 | 0.090 |
Why?
| Mass Vaccination | 1 | 2011 | 15 | 0.090 |
Why?
| Evidence-Based Medicine | 1 | 2015 | 675 | 0.090 |
Why?
| Prescriptions | 2 | 2022 | 60 | 0.090 |
Why?
| Health Care Costs | 1 | 2014 | 380 | 0.090 |
Why?
| Respiratory Syncytial Virus, Human | 2 | 2023 | 61 | 0.090 |
Why?
| Pneumonia, Pneumococcal | 1 | 2010 | 38 | 0.090 |
Why?
| Drug Recalls | 1 | 2010 | 5 | 0.090 |
Why?
| Medical Records Systems, Computerized | 1 | 2011 | 90 | 0.090 |
Why?
| Physicians, Primary Care | 1 | 2013 | 222 | 0.090 |
Why?
| Haemophilus influenzae | 1 | 2010 | 48 | 0.090 |
Why?
| Haemophilus Infections | 1 | 2010 | 28 | 0.090 |
Why?
| Feasibility Studies | 1 | 2013 | 737 | 0.090 |
Why?
| Emergency Service, Hospital | 1 | 2020 | 1813 | 0.090 |
Why?
| Medicare Part D | 1 | 2010 | 26 | 0.090 |
Why?
| Communication | 1 | 2015 | 749 | 0.090 |
Why?
| Polysaccharides, Bacterial | 1 | 2010 | 66 | 0.090 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2010 | 58 | 0.080 |
Why?
| Immunization, Secondary | 4 | 2013 | 82 | 0.080 |
Why?
| Patient Education as Topic | 2 | 2011 | 678 | 0.080 |
Why?
| Pertussis Vaccine | 1 | 2009 | 21 | 0.080 |
Why?
| Autistic Disorder | 1 | 2011 | 162 | 0.080 |
Why?
| Pregnancy Outcome | 2 | 2023 | 337 | 0.080 |
Why?
| Chickenpox | 1 | 2010 | 93 | 0.080 |
Why?
| Data Interpretation, Statistical | 2 | 2021 | 323 | 0.080 |
Why?
| Anemia, Sickle Cell | 1 | 2011 | 216 | 0.080 |
Why?
| Disease Susceptibility | 2 | 2020 | 316 | 0.080 |
Why?
| Neuralgia, Postherpetic | 1 | 2008 | 44 | 0.070 |
Why?
| Sensitivity and Specificity | 2 | 2019 | 1700 | 0.070 |
Why?
| Observational Studies as Topic | 2 | 2018 | 90 | 0.070 |
Why?
| Confidence Intervals | 2 | 2021 | 309 | 0.070 |
Why?
| Mortality | 2 | 2019 | 288 | 0.070 |
Why?
| Risk-Taking | 1 | 2009 | 333 | 0.070 |
Why?
| Health Surveys | 3 | 2017 | 443 | 0.060 |
Why?
| Cause of Death | 2 | 2019 | 363 | 0.060 |
Why?
| Urban Health | 1 | 2005 | 73 | 0.060 |
Why?
| Rural Health | 1 | 2005 | 67 | 0.060 |
Why?
| HIV Infections | 1 | 2019 | 2470 | 0.060 |
Why?
| Probability | 1 | 2005 | 291 | 0.060 |
Why?
| Office Automation | 1 | 2004 | 5 | 0.060 |
Why?
| Patient Selection | 1 | 2007 | 642 | 0.060 |
Why?
| Public Health Practice | 1 | 2004 | 61 | 0.060 |
Why?
| Epidural Space | 1 | 2003 | 6 | 0.060 |
Why?
| Toxoids | 1 | 2023 | 1 | 0.060 |
Why?
| Spinal Cord Compression | 1 | 2003 | 17 | 0.050 |
Why?
| Herpesvirus 3, Human | 2 | 2023 | 380 | 0.050 |
Why?
| Patient Care | 1 | 2004 | 103 | 0.050 |
Why?
| Health Services Accessibility | 1 | 2009 | 765 | 0.050 |
Why?
| Vibrio cholerae O1 | 1 | 2022 | 1 | 0.050 |
Why?
| Travel-Related Illness | 1 | 2022 | 6 | 0.050 |
Why?
| Antacids | 1 | 2022 | 15 | 0.050 |
Why?
| Blood Group Antigens | 1 | 2022 | 14 | 0.050 |
Why?
| Drug Utilization | 2 | 2013 | 167 | 0.050 |
Why?
| Dehydration | 1 | 2022 | 40 | 0.050 |
Why?
| Algorithms | 2 | 2020 | 1474 | 0.050 |
Why?
| Measles Vaccine | 1 | 2022 | 17 | 0.050 |
Why?
| Family Characteristics | 1 | 2023 | 152 | 0.050 |
Why?
| Treatment Outcome | 4 | 2019 | 9105 | 0.050 |
Why?
| Information Systems | 1 | 2021 | 61 | 0.050 |
Why?
| Safety-Based Drug Withdrawals | 1 | 2021 | 2 | 0.050 |
Why?
| Office Visits | 2 | 2015 | 79 | 0.050 |
Why?
| Drug Labeling | 1 | 2021 | 42 | 0.050 |
Why?
| Bacterial Capsules | 1 | 2020 | 28 | 0.050 |
Why?
| Epidemiologic Research Design | 2 | 2013 | 27 | 0.050 |
Why?
| Deltoid Muscle | 1 | 2020 | 4 | 0.040 |
Why?
| Fever | 1 | 2022 | 279 | 0.040 |
Why?
| Insurance Claim Reporting | 1 | 2020 | 22 | 0.040 |
Why?
| Injections, Intramuscular | 1 | 2020 | 118 | 0.040 |
Why?
| Morbidity | 1 | 2020 | 277 | 0.040 |
Why?
| Evidence-Based Practice | 1 | 2021 | 185 | 0.040 |
Why?
| Epidemiologic Methods | 1 | 2019 | 72 | 0.040 |
Why?
| Child Health Services | 1 | 2022 | 177 | 0.040 |
Why?
| Graphic Novels as Topic | 1 | 2019 | 1 | 0.040 |
Why?
| Water | 1 | 2022 | 399 | 0.040 |
Why?
| Student Health Services | 1 | 2019 | 16 | 0.040 |
Why?
| Florida | 1 | 2019 | 73 | 0.040 |
Why?
| Orthomyxoviridae | 1 | 2019 | 35 | 0.040 |
Why?
| Antihypertensive Agents | 1 | 2022 | 429 | 0.040 |
Why?
| History, 21st Century | 1 | 2019 | 161 | 0.040 |
Why?
| Gestational Age | 1 | 2021 | 759 | 0.040 |
Why?
| Pancreatitis | 1 | 2019 | 107 | 0.040 |
Why?
| Medical Informatics | 1 | 2019 | 92 | 0.040 |
Why?
| Birth Weight | 1 | 2021 | 440 | 0.040 |
Why?
| Patient Safety | 1 | 2022 | 278 | 0.040 |
Why?
| Weight Gain | 1 | 2022 | 451 | 0.040 |
Why?
| Appendicitis | 1 | 2019 | 109 | 0.040 |
Why?
| Stillbirth | 1 | 2018 | 57 | 0.040 |
Why?
| Croup | 1 | 2018 | 22 | 0.040 |
Why?
| Monte Carlo Method | 1 | 2018 | 137 | 0.040 |
Why?
| Minority Groups | 1 | 2019 | 228 | 0.040 |
Why?
| Linear Models | 1 | 2019 | 770 | 0.040 |
Why?
| Universities | 1 | 2019 | 339 | 0.030 |
Why?
| Propensity Score | 1 | 2018 | 224 | 0.030 |
Why?
| Prediabetic State | 1 | 2019 | 220 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2018 | 718 | 0.030 |
Why?
| Social Class | 1 | 2018 | 204 | 0.030 |
Why?
| Respiratory Sounds | 1 | 2017 | 111 | 0.030 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2021 | 1215 | 0.030 |
Why?
| Otitis Media | 1 | 2018 | 143 | 0.030 |
Why?
| Government Programs | 1 | 2015 | 22 | 0.030 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 1361 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2019 | 1801 | 0.030 |
Why?
| Cholesterol, HDL | 1 | 2014 | 184 | 0.030 |
Why?
| Insurance Coverage | 1 | 2015 | 202 | 0.030 |
Why?
| Off-Label Use | 1 | 2013 | 51 | 0.030 |
Why?
| Prognosis | 1 | 2020 | 3344 | 0.030 |
Why?
| Cholesterol, LDL | 1 | 2014 | 307 | 0.030 |
Why?
| Quality Control | 1 | 2012 | 144 | 0.030 |
Why?
| Antigens, Viral | 1 | 2013 | 176 | 0.030 |
Why?
| Tetanus Toxoid | 1 | 2012 | 37 | 0.030 |
Why?
| Triglycerides | 1 | 2014 | 470 | 0.030 |
Why?
| Encephalitis | 1 | 2014 | 127 | 0.030 |
Why?
| Professional Practice Location | 1 | 2011 | 26 | 0.020 |
Why?
| Survival Rate | 1 | 2016 | 1644 | 0.020 |
Why?
| Bell Palsy | 1 | 2011 | 6 | 0.020 |
Why?
| Physical Examination | 1 | 2013 | 220 | 0.020 |
Why?
| Comorbidity | 1 | 2016 | 1458 | 0.020 |
Why?
| Medically Uninsured | 1 | 2012 | 122 | 0.020 |
Why?
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 11 | 0.020 |
Why?
| Income | 1 | 2012 | 167 | 0.020 |
Why?
| Schools | 1 | 2014 | 400 | 0.020 |
Why?
| Pharmaceutical Services | 1 | 2011 | 79 | 0.020 |
Why?
| Fees, Pharmaceutical | 1 | 2010 | 13 | 0.020 |
Why?
| Job Satisfaction | 1 | 2011 | 168 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2017 | 2542 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2011 | 383 | 0.020 |
Why?
| Interviews as Topic | 1 | 2011 | 582 | 0.020 |
Why?
| Postal Service | 1 | 2008 | 29 | 0.020 |
Why?
| Health Behavior | 1 | 2013 | 704 | 0.020 |
Why?
| Health Care Rationing | 1 | 2007 | 45 | 0.020 |
Why?
| Efficiency, Organizational | 1 | 2008 | 126 | 0.020 |
Why?
| Demography | 1 | 2008 | 262 | 0.020 |
Why?
| Intussusception | 1 | 2007 | 27 | 0.020 |
Why?
| Mass Media | 1 | 2005 | 37 | 0.010 |
Why?
| Perception | 1 | 2007 | 311 | 0.010 |
Why?
| Policy Making | 1 | 2004 | 81 | 0.010 |
Why?
|
|
Daley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|